Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. tsdr pharmacy inc.
WARNING LETTER
•tsdr pharmacy inc. •March 28, 2017

tsdr pharmacy inc. – FDA Warning Letter, Mar 28, 2017

Record Details

An FDA inspection of TSDR Pharmacy, Inc. DBA brandMD Skin Care from March 20-28, 2017, revealed serious deficiencies in producing non-sterile drug products, posing patient risks. The firm's compounded drug products failed to meet Section 503A conditions of the FDCA, specifically by not receiving valid prescriptions for individually-identified patients for a portion of its products. This renders these products ineligible for exemptions from CGMP, adequate directions for use, and FDA approval requirements.

Violations included drug products being adulterated under Section 501(a)(2)(A) due to insanitary conditions, such as black oily residue on equipment and a lack of cleaning procedures. Significant CGMP violations were also observed, including failures to establish and follow adequate written procedures for equipment cleaning and maintenance (21 CFR 211.67(b)), establish laboratory controls (21 CFR 211.160(b)), establish a quality control unit (21 CFR 211.22(a)), establish adequate production and process control procedures (21 CFR 211.100(a)), and routinely calibrate equipment (21 CFR 211.68(a)).

Furthermore, the firm lacked FDA-approved applications for its ineligible compounded drugs, making them unapproved new drugs under Sections 505(a) and 301(d). These products were also deemed misbranded under Section 502(f)(1) because they lacked adequate directions for use for conditions not amenable to self-diagnosis.

FDA found the firm's April 11, 2017, response inadequate, particularly regarding insanitary conditions and the distribution of

Company
tsdr pharmacy inc.
Inspection date
March 28, 2017
Product type
Drugs
Office
Los Angeles District Office
Person
  • Kelli F. Dobilas (Pre-Approval Manager)
View Company Profile

ID · 40ff2eb4-3b3a-44af-a9a9-0571ed95ff98

Violation Codes10
21 U.S.C. 321(g)21 U.S.C. 351(a)(2)(B)21 U.S.C. 331(a)21 U.S.C. 353a21 U.S.C. 352(f)(1)21.U.S.C. 355(a)21 U.S.C. 331(k)21 U.S.C. 331(d)21 U.S.C. 321(p)21 CFR 211.67(b)

Full citation text and observation details available on the Dashboard.

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore tsdr pharmacy inc.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.